These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 24823644)

  • 1. Drug delivery: beyond active tumour targeting.
    Sagnella SM; McCarroll JA; Kavallaris M
    Nanomedicine; 2014 Aug; 10(6):1131-7. PubMed ID: 24823644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.
    Chen S; Yang K; Tuguntaev RG; Mozhi A; Zhang J; Wang PC; Liang XJ
    Nanomedicine; 2016 Feb; 12(2):269-86. PubMed ID: 26707818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine and chemotherapeutics drug delivery: challenges and opportunities.
    Nezhadi S; Saadat E; Handali S; Dorkoosh F
    J Drug Target; 2021 Feb; 29(2):185-198. PubMed ID: 32772739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Influencing the Delivery Efficiency of Cancer Nanomedicines.
    Ullah R; Wazir J; Khan FU; Diallo MT; Ihsan AU; Mikrani R; Aquib M; Zhou X
    AAPS PharmSciTech; 2020 May; 21(4):132. PubMed ID: 32409932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical oncology: New targets for nanomedicine.
    Nicolas-Boluda A; Silva AKA; Fournel S; Gazeau F
    Biomaterials; 2018 Jan; 150():87-99. PubMed ID: 29035739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotherapy Targeting the Tumor Microenvironment.
    Gong BS; Wang R; Xu HX; Miao MY; Yao ZZ
    Curr Cancer Drug Targets; 2019; 19(7):525-533. PubMed ID: 30569855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new era of pancreatic cancer treatment: Application of nanotechnology breaking through bottlenecks.
    Luo W; Zhang T
    Cancer Lett; 2024 Jul; 594():216979. PubMed ID: 38795762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy.
    Shi Y; van der Meel R; Chen X; Lammers T
    Theranostics; 2020; 10(17):7921-7924. PubMed ID: 32685029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Targeted Tumor Chemotherapy Based on Smart Nanomedicines.
    Qin SY; Zhang AQ; Zhang XZ
    Small; 2018 Nov; 14(45):e1802417. PubMed ID: 30247806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.
    Niu Y; Zhu J; Li Y; Shi H; Gong Y; Li R; Huo Q; Ma T; Liu Y
    J Control Release; 2018 May; 277():35-47. PubMed ID: 29545106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-based targeting of engineered nanocarrier against solid tumors: Recent progress and challenges ahead.
    Akhter MH; Beg S; Tarique M; Malik A; Afaq S; Choudhry H; Hosawi S
    Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129777. PubMed ID: 33130062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response.
    Gilabert-Oriol R; Ryan GM; Leung AWY; Firmino NS; Bennewith KL; Bally MB
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30261606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
    Danhier F
    J Control Release; 2016 Dec; 244(Pt A):108-121. PubMed ID: 27871992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boosting antitumor efficacy of nanoparticles by modulating tumor mechanical microenvironment.
    Zhang X; Zhang X; Yong T; Gan L; Yang X
    EBioMedicine; 2024 Jul; 105():105200. PubMed ID: 38876044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating the tumor microenvironment with new therapeutic nanoparticles: A promising paradigm for tumor treatment.
    Zhang Y; Ho SH; Li B; Nie G; Li S
    Med Res Rev; 2020 May; 40(3):1084-1102. PubMed ID: 31709590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of nanotechnology in remodeling the tumour microenvironment for glioblastoma treatment.
    Mu Y; Zhang Z; Zhou H; Ma L; Wang DA
    Biomater Sci; 2024 Aug; 12(16):4045-4064. PubMed ID: 38993162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment and nanotherapeutics: intruding the tumor fort.
    Ravi Kiran AVVV; Kusuma Kumari G; Krishnamurthy PT; Khaydarov RR
    Biomater Sci; 2021 Nov; 9(23):7667-7704. PubMed ID: 34673853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.